<DOC>
	<DOCNO>NCT00434772</DOCNO>
	<brief_summary>Thesis Infants diabetic mother high risk develop hypoglycemia birth . After birth , glucose ketone body main substrate brain energy . Under normal condition , adrenergic response see immediately birth suppresses insulin release stimulates glucagon secretion enhances gluconeogenesis ketogenesis . An inversion insulin/glucagon ratio see soon birth normal , physiologic phenomenon . Consequently , post delivery glucose nadir reach 30 90 minute birth , follow spontaneous recovery 3-4 hour age . In infant diabetic mother , inversion ratio postpone profound sustain hypoglycemia see . Early feeding great importance diminish severity incidence hypoglycemia . But , despite appropriate calorie intake , low level sugar see , intravenous infusion glucose commence . In case IV glucose effective ca n't supply immediately , intramuscular glucagon therapeutic alternative . We hypothesize single intramuscular injection glucagon together appropriate oral intake nutrient safe effective alternative IV infusion glucose alone treatment hypoglycemia term infant diabetic mother . Methods Appropriately grown large date , term infant insulin treat diabetic mother , know medical problem , potential candidate study . Hypoglycemia define serum glucose level lower 45 mg % . Infants diabetic mother arrive nursery immediately receive early feeding 30 minute life . At time , glucose check . If glucose level lower 45 mg % , treatment IV glucose IM glucagon initiate . Glucose check every hour 4 hour every 3 hour ( meal ) next 20 hour . In case blood glucose level low 20 mg % fall 45 mg % despite glucagon treatment , IV glucose immediately institute . Our aim check IM Glucagon good IV glucose treatment hypoglycemia infant diabetic mother . We compare glucose level treatment IV glucose IM glucagon , time till normalization glucose full feeding achieve number hospitalization day group .</brief_summary>
	<brief_title>Glucagon Treatment Hypoglycemia Newborn Infants Diabetic Mothers</brief_title>
	<detailed_description />
	<mesh_term>Hypoglycemia</mesh_term>
	<mesh_term>Fetal Diseases</mesh_term>
	<mesh_term>Pregnancy Diabetics</mesh_term>
	<mesh_term>Glucagon</mesh_term>
	<mesh_term>Glucagon-Like Peptide 1</mesh_term>
	<criteria>asymptomatic hypoglycemia infant insulin treat diabetic mother AGA LGA known medical problem concurrent medical problem symptomatic hypoglycemia glucose 20 mg %</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>48 Hours</maximum_age>
	<verification_date>May 2009</verification_date>
	<keyword>hypoglycemia</keyword>
	<keyword>glucagon</keyword>
	<keyword>neonatal</keyword>
	<keyword>gestational diabetes</keyword>
	<keyword>insulin</keyword>
	<keyword>glyburide</keyword>
</DOC>